Self-financed Drugs Available for Purchase by Patients at HA Pharmacies
As a publicly-funded healthcare provider, the Hospital Authority (HA) does not supply drugs as a retailer. Patients should in general purchase self-financed drugs from community pharmacies. However, three categories of self-financed drugs are available for purchase by patients at HA pharmacies, including (1) drugs covered by the safety net, (2) very specialized drugs not readily available at community pharmacies and (3) drugs for meeting operational needs (e.g. injections), as follows:
As of 28 May 2022
|
Drugs With Safety Net 安全網藥物
|
|
1.
ABATACEPT
|
|
2.
ABEMACICLIB
|
|
3.
ABIRATERONE
|
|
4. ACALABRUTINIB
|
|
5. ADALIMUMAB (HUMIRA / AMGEVITA)
|
|
6. AFATINIB
|
|
7. ALECTINIB
|
|
8. ATEZOLIZUMAB (TECENTRIQ)
|
|
9. AXITINIB
|
|
10. AZACITIDINE
|
|
11. BARICITINIB
|
|
12. BELIMUMAB
|
|
13. BENDAMUSTINE
|
|
14. BENRALIZUMAB
|
|
15. BEVACIZUMAB (AVASTIN / MVASI)
|
|
16. BORTEZOMIB
|
|
17. BRENTUXIMAB VEDOTIN
|
|
18. BRIGATINIB
|
|
19. CANAKINUMAB
|
|
20. CARFILZOMIB
|
|
21. CERITINIB
|
|
22. CERTOLIZUMAB
|
|
23. CETUXIMAB
|
|
24. CLADRIBINE
|
|
25. CRIZOTINIB
|
|
26. DABRAFENIB
|
|
27. DASATINIB
|
|
28. DOXORUBICIN (LIPOSOMAL)
|
|
29. DUPILUMAB
|
|
30. DURVALUMAB
|
|
31. ECULIZUMAB
|
|
32. ELTROMBOPAG
|
|
33. ENZALUTAMIDE
|
|
34. ETANERCEPT
|
|
35. EVEROLIMUS (AFINITOR)[TABLET]
|
|
36. GEFITINIB
|
|
37. GEMTUZUMAB OZOGAMICIN
|
|
38. GOLIMUMAB
|
|
39. GUSELKUMAB
|
|
40. IBRUTINIB
|
|
41. IMATINIB (GLIVEC)MESYLATE
|
|
42. INFLIXIMAB (REMICADE / REMSIMA)
|
|
43. INOTUZUMAB OZOGAMICIN
|
|
44. IPILIMUMAB
|
|
45. IXAZOMIB
|
|
46. IXEKIZUMAB
|
|
47. INTERFERON GAMMA-1B
|
|
48. LAPATINIB DITOSYLATE
|
|
49. LENALIDOMIDE
|
|
50. LENVATINIB
|
|
51. LETERMOVIR
|
|
52. MEPOLIZUMAB
|
|
53. MIDOSTAURIN
|
|
54. NATALIZUMAB
|
|
55. NILOTINIB HCl
|
|
56. NINTEDANIB (OFEV)ESILATE
|
|
57. NIVOLUMAB
|
|
58. NUSINERSEN
|
|
59. OBINUTUZUMAB
|
|
60. OLAPARIB
|
|
61. OMALIZUMAB
|
|
62. OSIMERTINIB
|
|
63. PALBOCICLIB
|
|
64. PANITUMUMAB
|
|
65. PAZOPANIB
|
|
66. PEMBROLIZUMAB
|
|
67. PERTUZUMAB
|
|
68. PHESGO
|
|
69. PLERIXAFOR
|
|
70. POMALIDOMIDE
|
|
71. PONATINIB
|
|
72. RIBOCICLIB
|
|
73. RISANKIZUMAB
|
|
74. RITUXIMAB (MABTHERA / RIXATHON / TRUXIMA)
|
|
75. RUXOLITINIB
|
|
76. SARILUMAB
|
|
77. SECUKINUMAB
|
|
78. SIPONIMOD
|
|
79. SORAFENIB
|
|
80. SUNITINIB
|
|
81. TAFAMIDIS
|
|
82. TAFAMIDIS MEGLUMINE
|
|
83. TEMOZOLOMIDE
|
|
84. TISAGENLECLEUCEL
|
|
85. TOCILIZUMAB
|
|
86. TOFACITINIB
|
|
87. TOLVAPTAN (JINARC)
|
|
88. TRAMETINIB
|
|
89. TRASTUZUMAB (HERCEPTIN / HERZUMA / KANJINTI)
|
|
90. TRASTUZUMAB EMTANSINE (KADCYLA)
|
|
91. UPADACITINIB
|
|
92. USTEKINUMAB
|
|
93. VEDOLIZUMAB
|
|
94. VEMURAFENIB
|
|
Antipsychotic Drugs 抗精神病藥
|
|
1. ARIPIPRAZOLE
|
|
2. CLOZAPINE
|
|
3. PALIPERIDONE
|
|
4. RISPERIDONE
|
|
Antidepressant Drugs 抗抑鬱藥
|
|
1.
AGOMELATINE
|
|
2.
BUPROPION
|
|
3.
DESVENLAFAXINE
|
|
4.
DULOXETINE
|
|
5.
ESCITALOPRAM
|
|
6.
FLUVOXAMINE
|
|
7.
MILNACIPRAN
|
|
8.
PAROXETINE
|
|
9.
VENLAFAXINE
|
|
10. VORTIOXETINE
|
|
Drugs for Dementia 腦退化症藥物
|
|
1. DONEPEZIL
|
|
2. GALANTAMINE
|
|
3. RIVASTIGMINE
|
|
Oncology Drugs 腫瘤科藥物
|
|
1. ANAGRELIDE (AGRYLIN / THROMBOREDUCTIN)
|
|
2. ANASTROZOLE
|
|
3. APALUTAMIDE
|
|
4. ARSENIC TRIOXIDE
|
|
5. BICALUTAMIDE
|
|
6. BLINATUMOMAB
|
|
7. BUSERELIN
|
|
8. BUSULPHAN
|
|
9. CABOZANTINIB
|
|
10. CLOFARABINE
|
|
11. CYPROTERONE
|
|
12. DACOMITINIB
|
|
13. DARATUMUMAB
|
|
14. DEGARELIX
|
|
15. DOCETAXEL
|
|
16. ERIBULIN
|
|
17. ERLOTINIB
|
|
18. ESTRAMUSTINE
|
|
19. EXEMESTANE
|
|
20. FLUDARABINE
|
|
21. FLUTAMIDE
|
|
22. FULVESTRANT
|
|
23. GOSERELIN
|
|
24. IFOSFAMIDE
|
|
25. IMATINIB (HEMATOR / IMAKREBIN) MESYLATE
|
|
26. LANREOTIDE
|
|
27. LEUPRORELIN
|
|
28. LEUPRORELIN (ELIGARD)
|
|
29. LONSURF
|
|
30. MITOXANTRONE
|
|
31. NERATINIB
|
|
32. NIRAPARIB
|
|
33. OCTREOTIDE
|
|
34. PACLITAXEL ALBUMIN
|
|
35. PEMETREXED
|
|
36. PHESGO
|
|
37. POLATUZUMAB VEDOTIN
|
|
38. REGORAFENIB
|
|
39. THIOTEPA
|
|
40. TOPOTECAN
|
|
41. TRIPTORELIN ACETATE / EMBONATE / PAMOATE
|
|
42. TS-1
|
|
43. VENETOCLAX
|
|
44. VINORELBINE
|
|
Immunosuppressants 免疫抑制劑
|
|
1. ANTITHYMOCYTE IMMUNOGLOBULIN
|
|
2. BASILIXIMAB
|
|
3. CYCLOSPORIN A
|
|
4. DIMETHYL FUMARATE
|
|
5. EVEROLIMUS (AFINITOR DISPERSIBLE TABLET / CERTICAN TABLET)
|
|
6. FINGOLIMOD
|
|
7. MYCOPHENOLATE
|
|
8. SIPONIMOD FUMARIC ACID
|
|
9. SIROLIMUS
|
|
10. TACROLIMUS
|
|
11. TERIFLUNOMIDE
|
|
Others 其他類別
|
|
1. AKYNZEO
|
|
2. APREPITANT
|
|
All Dangerous Drugs 所有危險藥物
|
|
All Injectable Drugs 所有注射藥物
|